Orthofix (OFIX) 2025 Earnings Outlook and Key Drivers
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
Articles — Page 2241
Bowhead Specialty 2025 Earnings: What Investors Need
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
Elanco (ELAN) 2025 Earnings: What Investors Should Know
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
Price Prediction: Arizona Just Advances XRP Digital Reserve
Arizona Senate Finance Committee advances a bill that could place XRP and DigiByte in a state Digital Assets Strategi...
Crypto Price Prediction Today: BTC, XRP, ETH Eye Key Levels
Bitcoin, XRP and Ethereum moved in narrow ranges on Feb. 24, 2026, as traders weigh macro data and liquidity conditio...
Bitcoin Slides Into Worst Profit Cycle as Supply Turns Red
Bitcoin has entered a stark profit-and-loss juncture, with a growing share of the supply losing money as prices hover...
FedEx First Major Company Sues for Full Tariff Refund
FedEx filed a lawsuit seeking a full refund of IEEPA duties, arguing harmed by the government orders. This move marks...
Economist Says Stock Market Has Grown Detached From Economy
A leading economist argues that the stock market has drifted away from the pace of everyday economic activity as grow...
Salesforce Stock Been Hard to Read as AI Fears Grow
Salesforce enters its earnings print amid a mood swing for cloud software, with AI investments weighing on profits an...
Financial Stocks Their Worst Start Sparks Value Spotting
The financial sector kicks off 2026 with its sharpest early-year drop in a decade. Analysts say high-ROE, low-P/E scr...
Buffett Multiplier: Exposure Berkshire with 2x Reach
A practical guide to doubling your Berkshire exposure using a Buffett-inspired approach. Learn how to structure a bal...
Repligen (RGEN) 2025 Earnings: Outlook & Takeaways
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...